Karl-Josef Langen Selected Research

Karl-Josef Langen Research Topics

Disease

79	Glioma (Gliomas) 01/2024 - 08/2002
62	Neoplasms (Cancer) 03/2024 - 07/2003
42	Brain Neoplasms (Brain Tumor) 04/2024 - 08/2002
28	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 07/2012
12	Alzheimer Disease (Alzheimer's Disease) 05/2023 - 09/2015
9	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2012
8	Necrosis 01/2023 - 09/2012
7	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 01/2018
5	Meningioma (Meningiomas) 05/2023 - 11/2012
5	Radiation Injuries (Radiation Sickness) 01/2020 - 01/2017
4	Stroke (Strokes) 01/2022 - 05/2015
4	Spinal Cord Diseases 09/2013 - 12/2010
4	Pathologic Constriction (Stenosis) 09/2013 - 12/2010
3	Melanoma (Melanoma, Malignant) 04/2024 - 10/2016
3	Residual Neoplasm 10/2019 - 01/2015
3	Infarction (Infarctions) 06/2019 - 11/2006
3	Brain Ischemia (Cerebral Ischemia) 01/2019 - 11/2006
3	Gliosis 08/2013 - 11/2006
3	Abscess 06/2008 - 05/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2006 - 03/2005
2	Parkinson Disease (Parkinson's Disease) 05/2024 - 01/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 06/2019
2	Ischemic Stroke 01/2022 - 06/2019
2	Oligodendroglioma 01/2022 - 01/2020
2	Brain Injuries (Brain Injury) 01/2022 - 06/2019
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 06/2019
2	Amyloidosis 06/2021 - 01/2021
2	Cognitive Dysfunction 06/2021 - 01/2019
2	Medulloblastoma 01/2021 - 09/2016
2	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2005
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2020 - 01/2017
2	Seizures (Absence Seizure) 10/2020 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 04/2019 - 10/2015
2	Ischemia 01/2019 - 11/2006
2	Prostatic Neoplasms (Prostate Cancer) 02/2018 - 03/2005
2	Nervous System Diseases (Neurological Disorders) 10/2015 - 05/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2006 - 03/2005
1	REM Sleep Behavior Disorder 05/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Amyloid Plaque 06/2021
1	Epilepsy (Aura) 10/2020

Drug/Important Bio-Agent (IBA)

54	Tyrosine (L-Tyrosine)FDA Link 04/2024 - 07/2003
50	Amino Acids FDA Link 04/2024 - 11/2006
13	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 07/2012
11	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2023 - 01/2018
7	Amyloid (Amyloid Fibrils)IBA 05/2023 - 09/2015
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2002
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 03/2005
5	(18F)fluoroethyltyrosineIBA 01/2020 - 05/2006
5	Proline (L-Proline)FDA Link 04/2019 - 11/2008
5	Bevacizumab (Avastin)FDA Link 12/2018 - 01/2013
5	Peptides (Polypeptides)IBA 03/2018 - 01/2014
5	thiamine triphosphorate (TTP)IBA 01/2018 - 12/2013
4	Lomustine (CCNU)FDA Link 01/2023 - 07/2012
4	Methionine (L-Methionine)FDA Link 10/2019 - 07/2003
3	EnzymesIBA 05/2023 - 01/2020
3	LigandsIBA 10/2021 - 11/2012
3	Dihydroxyphenylalanine (Dopa)IBA 01/2021 - 05/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 05/2020 - 06/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2013 - 12/2010
2	regorafenibIBA 01/2023 - 05/2019
2	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2022 - 11/2012
2	Neuroprotective AgentsIBA 01/2022 - 06/2019
2	ArgonIBA 01/2022 - 06/2019
2	fluorodopa F 18IBA 01/2022 - 09/2016
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2019
2	SodiumIBA 10/2020 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 10/2019 - 06/2019
2	OsteopontinIBA 01/2019 - 01/2017
2	Phenylalanine (L-Phenylalanine)FDA Link 01/2017 - 01/2015
2	Amyloid beta-PeptidesIBA 11/2016 - 08/2016
2	Dopamine (Intropin)FDA LinkGeneric 10/2015 - 10/2012
2	AcidsIBA 04/2013 - 04/2011
2	GadoliniumIBA 07/2012 - 11/2004
1	Glutamic Acid (Glutamate)FDA Link 05/2024
1	Chimeric Antigen ReceptorsIBA 11/2023
1	Alkylating AgentsIBA 05/2023
1	OsseusIBA 05/2023
1	AntigensIBA 12/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	DeoxyuridineIBA 10/2021
1	RadiopharmaceuticalsIBA 10/2021
1	NanogelsIBA 10/2021
1	polyethylene glycol polyethyleneimine nanogelIBA 10/2021
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 10/2021
1	ThymidineIBA 10/2021
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 06/2021
1	MethyltransferasesIBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	Pentylenetetrazole (Metrazol)IBA 10/2020

Therapy/Procedure

33	Therapeutics 04/2024 - 08/2002
24	Radiotherapy 04/2024 - 01/2007
10	Drug Therapy (Chemotherapy) 10/2023 - 01/2015
7	Chemoradiotherapy 11/2018 - 07/2012
6	Immunotherapy 11/2022 - 01/2017
3	Combined Modality Therapy 04/2024 - 12/2018
3	Aftercare (After-Treatment) 12/2018 - 07/2012